Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2025-12-26 @ 9:23 PM
Study NCT ID:
NCT00609804
Status:
COMPLETED
Last Update Posted:
2016-04-08
First Post:
2008-01-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib
Sponsor:
SCRI Development Innovations, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-03
Start Date Type:
None
Primary Completion Date:
2012-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-11
Completion Date Type:
ACTUAL
First Submit Date:
2008-01-24
First Submit QC Date:
None
Study First Post Date:
2008-02-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-04-24
Results First Submit QC Date:
None
Results First Post Date:
2015-06-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-03-10
Last Update Post Date:
2016-04-08
Last Update Post Date Type:
ESTIMATED